<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbh="https://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://www.w3.org/ns/prov#" xmlns:ns1="http://purl.org/dc/elements/1.1/" xmlns:ns2="http://purl.org/dc/terms/" xmlns:ns3="http://purl.obolibrary.org/obo/">
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00202_2_comp/1">
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb8b00202/suppl/sb-2018-00202a_si_001.pdf"/>
    <sbol:displayId>sb8b00202_2_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_2_comp"/>
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00202"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00202_2_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00202_2_sequence/1">
    <sbol:elements>gattcgtcagtagggttgtaaaggtttttcttttcctgagaaaacaaccttttgttttctcaggttttgctttttggcctttccctagctttaaaaaaaaaaaagcaaaa</sbol:elements>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb8b00202_2_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00202_2_sequence"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00202_3_comp/1">
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00202"/>
    <sbol:version>1</sbol:version>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00202_3_sequence/1"/>
    <sbol:displayId>sb8b00202_3_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_3_comp"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb8b00202/suppl/sb-2018-00202a_si_001.pdf"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00202_4_sequence/1">
    <sbol:elements>ccattgttcaatatcgtccg</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00202_4_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb8b00202_4_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00202_4_comp/1">
    <sbol:displayId>sb8b00202_4_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00202"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_4_comp"/>
    <sbol:version>1</sbol:version>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00202_4_sequence/1"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb8b00202/suppl/sb-2018-00202a_si_001.pdf"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00202_5_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:elements>ggtgccctatgagccgcctg</sbol:elements>
    <sbol:displayId>sb8b00202_5_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00202_5_sequence"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00202_3_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb8b00202_3_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00202_3_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>gatccactcacagtttccat</sbol:elements>
  </sbol:Sequence>
  <sbol:Collection rdf:about="http://examples.org/sb8b00202/1">
    <ns1:subject>green florescent protein</ns1:subject>
    <ns1:subject>CRISPR-Cas9</ns1:subject>
    <ns1:subject>cell lines</ns1:subject>
    <ns1:subject>5637 cell line</ns1:subject>
    <ns1:subject>Cancer Cell Lines 293T</ns1:subject>
    <ns1:subject>green fluorescent protein</ns1:subject>
    <ns1:subject>poly-</ns1:subject>
    <ns1:creator>Hengji Zhan</ns1:creator>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_2_comp/1"/>
    <ns2:title>Synthesizing a Genetic Sensor Based on CRISPR-Cas9 for Specifically Killing p53-Deficient Cancer Cells</ns2:title>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_5_comp/1"/>
    <ns1:subject>EGFP</ns1:subject>
    <sbol:persistentIdentity rdf:resource="http://examples.org/sb8b00202"/>
    <ns1:subject>cells</ns1:subject>
    <ns1:subject>Pol II</ns1:subject>
    <sbol:displayId>sb8b00202</sbol:displayId>
    <ns2:references>Liu, Y., Zhang, X., Han, C., Wan, G., Huang, X., Ivan, C., Jiang, D., Rodriguez-Aguayo, C., Lopez-Berestein, G., Rao, P. H., Maru, D. M., Pahl, A., He, X., Sood, A. K., Ellis, L. M., Anderl, J., Lu, X., Krastev, D. B., Slabicki, M., Paszkowski-Rogacz, M., Hubner, N. C., Junqueira, M., Shevchenko, A., Mann, M., Neugebauer, K. M., Buchholz, F. TP53 loss creates therapeutic vulnerability in colorectal cancerA systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly NatureNat. Cell Biol. 20152011. 520:697-701.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_1_comp/1"/>
    <ns1:subject>nuclease Cas9</ns1:subject>
    <ns1:subject>streptomycin.</ns1:subject>
    <ns1:subject>Cas9</ns1:subject>
    <ns2:references>Hainaut, P., Hollstein, M. p53 and human cancer: the first ten thousand mutations Adv. Cancer Res. 2000. 77:81-137.</ns2:references>
    <ns1:subject>caspase-3 protease</ns1:subject>
    <ns1:subject>p53</ns1:subject>
    <ns2:references>Levine, A. J., Lane, D. P. p53, the cellular gatekeeper for growth and divisionCancer. p53, guardian of the genome CellNature 19971992. 88:323-31.</ns2:references>
    <ns1:subject>GAPDH</ns1:subject>
    <ns1:subject>293T cells</ns1:subject>
    <ns2:references>Melo, C. A., Leveille, N., Rooijers, K., Wijchers, P. J., Geeven, G., Tal, A., Melo, S. A., de Laat, W., Agami, R. A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response Oncogene 2016. 35:4399-406.</ns2:references>
    <ns1:subject>caspase-3</ns1:subject>
    <ns2:description>Cancer is still one of the greatest medical challenges in the world. The p53 protein plays an important role in the process of cancer formation. In addition, p53 is found as the most common mutant gene in cancers. Because of the central role of p53 in oncology, it is necessary to construct effective sensors to detect this protein. However, there are few methods to detect wild type p53 protein (WTP53) or to distinguish the wild type and mutant p53 proteins. In our study, we designed and constructed a p53 genetic sensor that detected the expression of WTP53 in cells. Moreover, we combined the p53 sensor with diphtheria toxin using the CRISPR-Cas9 system to construct a p53 genetic sensor that specifically killed p53-deficient cells such as tumor cells. Our study therefore developed a new way to treat cancers by using an available genetic sensor based on p53 protein.</ns2:description>
    <ns1:subject>hCas9</ns1:subject>
    <ns1:subject>393 amino acid peptide</ns1:subject>
    <ns1:subject>P53BER</ns1:subject>
    <ns3:OBI_0002110 rdf:resource="https://doi.org/10.1021/acssynbio.8b00202"/>
    <ns1:subject>far-red fluorescence protein</ns1:subject>
    <ns1:subject>diphtheria toxin</ns1:subject>
    <ns2:references>Levine, A. J., Oren, M. The first 30 years of p53: growing ever more complex Nat. Rev. Cancer 2009. 9:749-58.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_4_comp/1"/>
    <ns2:references>Yin, H., Song, C. Q., Suresh, S., Wu, Q., Walsh, S., Rhym, L. H., Mintzer, E., Bolukbasi, M. F., Zhu, L. J., Kauffman, K., Mou, H., Oberholzer, A., Ding, J., Kwan, S. Y., Bogorad, R. L., Zatsepin, T., Koteliansky, V., Wolfe, S. A., Xue, W., Langer, R., Anderson, D. G. Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing Nat. Biotechnol. 2017. 35.</ns2:references>
    <ns1:subject>5637 cells</ns1:subject>
    <ns2:references>Leroy, B., Anderson, M., Soussi, T. TP53 mutations in human cancer: database reassessment and prospects for the next decade Hum. Mutat. 2014. 35:672-88.</ns2:references>
    <ns1:subject>CRISPR</ns1:subject>
    <ns1:subject>penicillin</ns1:subject>
    <ns1:subject>streptomycin</ns1:subject>
    <ns2:references>Zhang, J., Kale, V., Chen, M. Gene-directed enzyme prodrug therapy AAPS J. 2015. 17:102-10.</ns2:references>
    <ns2:isPartOf>ACS Synthetic
Biology</ns2:isPartOf>
    <ns1:subject>Cells</ns1:subject>
    <ns2:references>Proudfoot, N. J. Ending the message: poly-(A) signals then and now Genes Dev. 2011. 25:1770-82.</ns2:references>
    <ns1:subject>lines</ns1:subject>
    <ns1:subject>poly-(</ns1:subject>
    <ns1:subject>MALAT1</ns1:subject>
    <ns1:subject>p53 bound enhancer</ns1:subject>
    <ns2:references>Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., Leiserson, M. D. M., Miller, C. A., Welch, J. S., Walter, M. J., Wendl, M. C., Ley, T. J., Wilson, R. K., Raphael, B. J., Ding, L., Hainaut, P., Pfeifer, G. P. Mutational landscape and significance across 12 major cancer typesSomatic TP53 Mutations in the Era of Genome Sequencing NatureCold Spring Harbor Perspect. Med. 20132016. 502:333-339.</ns2:references>
    <ns1:subject>R175H: KO cells</ns1:subject>
    <ns2:references>Liu, Y., Zeng, Y., Liu, L., Zhuang, C., Fu, X., Huang, W., Cai, Z. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells Nat. Commun. 2014. 5.</ns2:references>
    <ns1:subject>WTP53: KO cells</ns1:subject>
    <ns1:subject>Caspase-3</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00202_4_sequence/1"/>
    <ns1:subject>noWTP53</ns1:subject>
    <ns1:subject>P53</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_3_comp/1"/>
    <ns1:subject>NLS</ns1:subject>
    <ns2:rightsHolder>American Chemical
Society</ns2:rightsHolder>
    <ns2:abstract>Cancer is still one of the greatest medical challenges in the world. The p53 protein plays an important role in the process of cancer formation. In addition, p53 is found as the most common mutant gene in cancers. Because of the central role of p53 in oncology, it is necessary to construct effective sensors to detect this protein. However, there are few methods to detect wild type p53 protein (WTP53) or to distinguish the wild type and mutant p53 proteins. In our study, we designed and constructed a p53 genetic sensor that detected the expression of WTP53 in cells. Moreover, we combined the p53 sensor with diphtheria toxin using the CRISPR-Cas9 system to construct a p53 genetic sensor that specifically killed p53-deficient cells such as tumor cells. Our study therefore developed a new way to treat cancers by using an available genetic sensor based on p53 protein.</ns2:abstract>
    <ns1:subject>knockout cell line</ns1:subject>
    <ns2:references>Haellman, V., Fussenegger, M. Synthetic Biology&#8211;Toward Therapeutic Solutions J. Mol. Biol. 2016. 428:945-62.</ns2:references>
    <sbol:version>1</sbol:version>
    <ns2:references>Farzadfard, F., Perli, S. D., Lu, T. K., Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., Church, G. M., Ran, F.
A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., Zhang, F. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/CasRNA-guided human genome engineering via Cas9Genome engineering using the CRISPR-Cas9 system ACS Synth. Biol.ScienceNat. Protoc. 201320132013. 2:604-13.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00202_2_sequence/1"/>
    <ns2:references>Ding, C., Chan, D. W., Liu, W., Liu, M., Li, D., Song, L., Li, C., Jin, J., Malovannaya, A., Jung, S. Y., Zhen, B., Wang, Y., Qin, J. Proteome-wide profiling of activated transcription factors with a concatenated tandem array of transcription factor response elements Proc. Natl. Acad. Sci. U. S. A. 2013. 110:6771-6.</ns2:references>
    <ns1:subject>HCT116 cell line</ns1:subject>
    <ns1:subject>GFP</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00202_5_sequence/1"/>
    <ns1:subject>293T</ns1:subject>
    <ns1:subject>normal cell lines</ns1:subject>
    <ns2:dateCopyrighted>2018</ns2:dateCopyrighted>
    <ns1:subject>BamHI</ns1:subject>
    <ns2:references>Bouaoun, L., Sonkin, D., Ardin, M., Hollstein, M., Byrnes, G., Zavadil, J., Olivier, M. TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data Hum. Mutat. 2016. 37:865-76.</ns2:references>
    <ns1:subject>KO cell line</ns1:subject>
    <ns1:publisher>American
Chemical Society</ns1:publisher>
    <ns2:dateAccepted>2018-06-29</ns2:dateAccepted>
    <ns1:subject>mKate</ns1:subject>
    <ns1:subject>hEF1a-DT</ns1:subject>
    <ns1:subject>293T embryonic kidney cells</ns1:subject>
    <ns1:subject>WTP53</ns1:subject>
    <ns1:subject>human</ns1:subject>
    <ns1:subject>p53KO</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00202_3_sequence/1"/>
    <ns1:subject>nucleic acid</ns1:subject>
    <ns2:references>Vousden, K. H., Prives, C., Tonnessen-Murray, C. A., Lozano, G., Jackson, J. G., Williams, A. B., Schumacher, B. Blinded by the Light: The Growing Complexity of p53The Regulation of Cellular Functions by the p53 Protein: Cellular Senescencep53 in the DNA-Damage-Repair Process CellCold Spring Harbor Perspect. Med.Cold Spring Harbor Perspect. Med. 200920172016. 137:413-31.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00202_1_sequence/1"/>
    <ns1:subject>type p53</ns1:subject>
    <ns1:type>research-article</ns1:type>
    <ns1:subject>line</ns1:subject>
    <ns2:references>Baugh, E. H., Ke, H., Levine, A. J., Bonneau, R. A., Chan, C. S. Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ. 2018. 25:154-160.</ns2:references>
    <ns1:subject>transcription factors</ns1:subject>
    <ns1:subject>Esp3I</ns1:subject>
    <ns2:references>Wilusz, J. E., JnBaptiste, C. K., Lu, L. Y., Kuhn, C. D., Joshua-Tor, L., Sharp, P. A. A triple helix stabilizes the 3&#8242; ends of long noncoding RNAs that lack poly-(A) tails Genes Dev. 2012. 26:2392-407.</ns2:references>
    <ns2:references>Campomenosi, P., Monti, P., Aprile, A., Abbondandolo, A., Frebourg, T., Gold, B., Crook, T., Inga, A., Resnick, M. A., Iggo, R., Fronza, G. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements Oncogene 2001. 20:3573-9.</ns2:references>
    <ns1:subject>bovine</ns1:subject>
    <ns1:subject>Bam HI</ns1:subject>
    <ns3:OBI_0001617>29957992</ns3:OBI_0001617>
    <ns1:subject>(DT:</ns1:subject>
    <ns2:references>Scharer, E., Iggo, R. Mammalian p53 can function as a transcription factor in yeast Nucleic Acids Res. 1992. 20:1539-45.</ns2:references>
    <ns1:subject>Hind</ns1:subject>
    <ns1:subject>DT</ns1:subject>
    <ns1:subject>p53BER</ns1:subject>
    <ns1:subject>CRISPR-associated (Cas) system</ns1:subject>
    <ns1:subject>transcription factor</ns1:subject>
    <ns2:references>Liu, Y., Zhan, Y., Chen, Z., He, A., Li, J., Wu, H., Liu, L., Zhuang, C., Lin, J., Guo, X., Zhang, Q., Huang, W., Cai, Z. Directing cellular information flow via CRISPR signal conductors Nat. Methods 2016. 13:938-944.</ns2:references>
    <ns0:wasDerivedFrom rdf:resource="https://pubs.acs.org/doi/10.1021/acssynbio.8b00202"/>
    <ns2:dateSubmitted>2018-05-13</ns2:dateSubmitted>
    <ns2:references>Melo, C. A., Drost, J., Wijchers, P. J., van de Werken, H., de Wit, E., Oude Vrielink, J. A., Elkon, R., Melo, S. A., Leveille, N., Kalluri, R., de Laat, W., Agami, R. eRNAs are required for p53-dependent enhancer activity and gene transcription Mol. Cell 2013. 49:524-35.</ns2:references>
    <ns1:creator>Yuchen Liu</ns1:creator>
    <ns1:subject>HCT116 cells</ns1:subject>
    <ns2:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <ns1:subject>SV40</ns1:subject>
    <ns1:subject>P53BER (A</ns1:subject>
    <ns2:created>2018-06-29</ns2:created>
    <ns1:subject>peptide</ns1:subject>
    <ns1:subject>hEF1a</ns1:subject>
    <ns2:references>Kalderon, D., Roberts, B. L., Richardson, W. D., Smith, A. E. A short amino acid sequence able to specify nuclear location Cell 1984. 39:499-509.</ns2:references>
    <ns1:subject>Hind III</ns1:subject>
    <ns2:references>Oliner, J. D., Saiki, A. Y., Caenepeel, S., Moll, U. M., Ostermeyer, A. G., Haladay, R., Winkfield, B., Frazier, M., Zambetti, G., Lechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H., Laimins, L. A. The Role of MDM2 Amplification and Overexpression in TumorigenesisCytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damageHuman papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription Cold Spring Harbor Perspect. Med.Mol. Cell. Biol.EMBO J. 201619961992. 6:a026336-37.</ns2:references>
    <ns1:subject>EcoRV</ns1:subject>
    <ns1:creator>Weiren Huang</ns1:creator>
    <ns2:references>Kondo, Y., Oubridge, C., van Roon, , Nagai, K. Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5&#8242; splice site recognition eLife 2015.</ns2:references>
    <ns1:subject>Cas</ns1:subject>
    <ns1:subject>genetic senor</ns1:subject>
    <ns1:creator>Qun Zhou</ns1:creator>
    <ns2:references>Seymour, L. W., Fisher, K. D. Oncolytic viruses: finally delivering Br. J. Cancer 2016. 114:357-61.</ns2:references>
    <ns1:creator>Haibiao Xie</ns1:creator>
    <ns2:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <ns1:subject>Pol III</ns1:subject>
  </sbol:Collection>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00202_1_sequence/1">
    <sbol:displayId>sb8b00202_1_sequence</sbol:displayId>
    <sbol:elements>atggtcattcaccatgcaacctctgctgttaacagatttcagactgtaatcttttgtttcttctttctaatcctgcacttcctctgactgttccattttggttccgagcaagcaggccgcttgtgtctgaatctggccaatcctgaaatctctgcttggctttgtcagacaagttcaggcatgcacagacatgtccatgagtttctcagaaggttgactctgccaaagccagaacaccactcccccactttccactgggtcctgtgctccaagctattggacataagtttgtgctttcgaaacttcagtatttacacggaatctgtg</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00202_1_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00202_5_comp/1">
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00202_5_sequence/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_5_comp"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb8b00202/suppl/sb-2018-00202a_si_001.pdf"/>
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00202"/>
    <sbol:displayId>sb8b00202_5_comp</sbol:displayId>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00202_1_comp/1">
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb8b00202_1_comp</sbol:displayId>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00202_1_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00202_1_comp"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00202"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb8b00202/suppl/sb-2018-00202a_si_001.pdf"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
</rdf:RDF>
